ClinicalTrials.gg
Active, not recruitingNCT05075759SALSAUpdated Oct 27, 2026

Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer

An interventional study of Behavioral Intervention and Behavioral Intervention in Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, sponsored by Fred Hutchinson Cancer Center. Active, not recruiting at 2 sites in United States. Open to participants aged 18 Years to 54 Years. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Fred Hutchinson Cancer Center · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
374
Allocation
Randomized
Ages
18 Years to 54 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Hematologic Neoplasms by Fred Hutchinson Cancer Center — 3 open to participants now, 7 under way, none of them phase 3. Hematologic Neoplasms · Fred Hutchinson Cancer Center.

Enrollment
6th of 24
374 · median 52
Started
2022
with 5 others
No phase
5 of 28
1 open now
Registered
25th of 28
by date

Among the 28 studies in Hematologic Neoplasms by Fred Hutchinson Cancer Center, this one is the 6th largest by enrollment of the 24 interventional ones that give a count, is one of 6 that started in 2022, is one of 5 with no phase, and was the 25th registered.

Hematologic Neoplasms

1,449 studies on the registry are indexed under Hematologic Neoplasms; 422 are open to participants now.

Browse Hematologic Neoplasms studies →

Open to participants now

3 of the 28 studies in Hematologic Neoplasms by Fred Hutchinson Cancer Center are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 313 Hematologic Neoplasms studies recruiting now, 209 (67%) set no upper age limit and 78 (25%) stop at 75 or younger; 81 take children under 18; 34 take healthy volunteers.

This study: 18 Years to 54 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Hematologic Neoplasms by Fred Hutchinson Cancer Center, or all of them as a file.
02

Study summary

This clinical trial evaluates several behavioral interventions for the improvement of physical activity in cancer patients. Childhood and adolescent/young adult cancer survivors have been reported to have poor diet quality and rarely meet recommended physical activity guidelines. This trial aims to see whether a tailored intervention based on self-determination theory may help to improve physical activity and dietary change.

Read the detailed description

OUTLINE: Patients are randomized to Arms 1, 2, or 3.

ARM 1: Patients receive a personalized clinician-led self-management telehealth session at baseline and 2 months. Patients with poor response at 3 months are randomized to Arm 2 or 4, otherwise patients receive the same telehealth session at months 4 and 6. Patients may receive 2 additional telehealth sessions after 6 months.

ARM 2: Patients receive personalized goal setting for daily steps and activity (updated weekly) and 3 dietary goals (updated monthly) with social media peer support for 6 months. Patients with poor response at 3 months are randomized to Arms 1 or 4. Patients may receive personalized goal setting for daily steps and activity (updated monthly) and dietary goals (updated every 2 months) after 6 months.

ARM 3: Patients receive no intervention for 12 months. After 12 months, they may optionally receive their choice of intervention for up to 6 months.

ARM 4: If Arms 1 or 2 patients have poor response after 3 months, patients may be re-randomized to Arm 4. Patients receive remote sessions with a health coach every 1-2 weeks for 3 months. Patients may continue to receive remote sessions once a month after 3 months, during the maintenance phase (months 6-12).

03

Conditions studied

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
04

Who can participate

Ages eligible
18 Years to 54 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Childhood Cancer Survivor Study (CCSS) participant who is between age 18 to \< 55 years at time of initial approach
  • Moderate to high CV risk status based on CCSS risk prediction models for cardiomyopathy and ischemic heart disease
  • Able to read, write, and speak English
  • Ability to understand and the willingness to provide
  • At least one of the following:

    • Less than 30 minutes/day of moderate to vigorous physical activity (MVPA) based on validated self-report instrument (Godin)
    • Healthy Eating Index (HEI)-2015 score \< 60 per study food frequency questionnaire (FFQ)
    • (BMI) >= 25 kg/m\^2 per self-reported height and weight
  • Be free of any known (self-reported) ischemic heart disease or cardiomyopathy
  • Have internet access (can be via smartphone or computer; if neither device is available, the study can loan participants a Wi-Fi enabled device, but participant will need to have access to the internet)

Exclusion criteria

Exclusion Criteria:

  • Individuals with known cardiomyopathy or ischemic heart disease based on prior CCSS surveys are excluded. While not likely to be common, participants who newly report in our study's screening questionnaire that they have newly diagnosed cardiomyopathy or ischemic heart disease will also be excluded
  • Having any self-reported to walking or being physically active
  • Not currently known to be pregnant; individuals known to be pregnant and otherwise eligible for the study can be enrolled once no longer known to be pregnant. Participants who report being pregnant after randomization can remain in the study
  • Individuals receiving active cancer treatment. Participants who report starting active cancer treatment after randomization can remain in the study
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
374 participants (actual)

Study arms

  • Experimental
    Arm 1 (personalized clinician-led self-management telehealth)

    Patients receive a personalized clinician-led self-management telehealth session at baseline and 2 months. Patients with poor response at 3 months are randomized to Arm 2 or 4, otherwise patients receive the same telehealth session at months 4 and 6. Patients may receive 2 additional telehealth sessions after 6 months.

    Behavioral: Behavioral Intervention · Other: Survey Administration · Other: Interview

  • Experimental
    Arm 2 (personalized goal setting)

    Patients receive personalized goal setting for daily steps and activity (updated weekly) and 3 dietary goals (updated monthly) with social media peer support for 6 months. Patients with poor response at 3 months are randomized to Arms 1 or 4. Patients may receive personalized goal setting for daily steps and activity (updated monthly) and dietary goals (updated monthly) after 6 months.

    Behavioral: Behavioral Intervention · Other: Survey Administration · Other: Interview

  • Active comparator
    Arm 3 (waitlist)

    Patients receive no intervention for 12 months. After 12 months, they may optionally receive their choice of intervention for up to 6 months.

    Other: Survey Administration · Other: Interview

  • Experimental
    Arm 4 (remote sessions with a health coach)

    Arm 1 and 2 patients with poor response after 3 months can be re-randomized to Arm 4. Patients receive remote sessions with a health coach every 1-2 weeks for 3 months. Patients may continue to receive remote sessions once a month after 3 months, during the maintenance phase (months 6-12).

    Behavioral: Behavioral Intervention · Other: Survey Administration

Interventions

  • BehavioralBehavioral Intervention

    Receive personalized clinician-led self-management telehealth sessions

    Also known as: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments

  • BehavioralBehavioral Intervention

    Receive personalized goal setting for daily steps and activity and dietary goals

    Also known as: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments

  • BehavioralBehavioral Intervention

    Remote sessions with a health coach

    Also known as: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments

  • OtherSurvey Administration

    Ancillary studies

  • OtherInterview

    Ancillary studies

06

What researchers measure

Primary outcomes

  1. Sedentary time

    \<100 counts/minute as measured by research-grade accelerometry

    Time frame: Up to 12 months

  2. Healthy Eating Index (HEI)-2015 score

    On a scale of 100 (perfect score) as measured by Food Frequency Questionnaire

    Time frame: Up to 12 months

Secondary outcomes

  1. Participant engagement

    As measured by: 1) response to clinician action plans \[score of 0-10; 10 being most engaged\]; 2) use of mHealth apps \[e.g., number of days with daily steps ≥500; number of days with recorded calories ≥500; social media interactions counting viewing, liking, or posting comments\]; and 3) number of sessions completed with lifestyle health coach and coach's rating of engagement \[score of 0-10; 10 being most engaged\]

    Time frame: Up to 12 months

  2. Health-related self-efficacy scale

    Per Schwarzer R, et al. and converted to T-score (higher equaling greater self-efficacy)

    Time frame: Up to 12 months

  3. Multidimensional Health Locus of Control Scale

    Per Wallston KA, et al. with 3 subscales: internal, chance, and powerful others (each scored from 6-36, with higher values indicating greater agreement with that subscale's locus on control beliefs)

    Time frame: Up to 12 months

07

Study locations

2 sites
08

References and documents

Publications

  • Chow E, Lee E, Hershberger M, Jenssen K, Di C, Doody D, Hogue B, Mendoza J, Muller T, Schenk J, Syrjala K, Xu Y, Yi J, Zhao YQ, Armstrong G, Neuhouser M, Oeffinger K. Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer. JMIR Res Protoc. 2026 Aug 13;15:e104572. doi: 10.2196/104572. PubMed 42594273 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2022 (actual). Primary completion is estimated for Dec 2026, 54 months after the start.

Of 186 non-industry interventional studies with no phase under Hematologic Neoplasms, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 125. This study's planned 54 months is above that.

Counting every sponsor, half of 192 studies reached it within 40 months; a quarter within 21 and three quarters within 82.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2021
First posted
Oct 13, 2021
StartActual
Jun 6, 2022
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42594273 ↗
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42594273 ↗
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05075759
Responsible party
Sponsor
First posted
Oct 13, 2021
Start date
Jun 6, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 27, 2026

Study contacts

Eric J. Chow
principal investigator · Fred Hutch/University of Washington Cancer Consortium

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion